Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

Amyotrophic lateral sclerosis could soon be diagnosed from a muscle biopsy thanks to a possible diagnostic biomarker that’s been identified in muscle tissue. Amyotrophic lateral sclerosis (ALS) is a ...

Proposed McDonald criteria revisions could help diagnose MS patients who would have been missed with earlier versions, an ...

WEST PALM BEACH, Fla. — New research testing the newly proposed McDonald Criteria showed that 32% more patients with a ...

The absence of a formal ALS diagnosis can ... hinder the planning and medical management of PMA When a patient presents to the clinic with weakness, a frequent concern is whether the symptoms ...

For the early detection of Alzheimer's disease, so-called p-tau proteins in the blood are not as disease-specific as ...

Get Instant Summarized Text (Gist) A study identifies neurofilament light chain proteins as effective blood biomarkers for diagnosing and monitoring ALS, showing over 80% accuracy. These proteins ...

as defined by El Escorial Revised ALS diagnostic criteria, using fasudil or its active metabolite. Further claims are directed to reducing neurofilament light (NfL). Woolsey also has Orphan Drug ...

Measuring blood levels of NfL, a biomarker of nerve damage, could help diagnose ALS and predict the risk of death for ...